Cagrilintide (10ml)
$119.00
A long-acting synthetic amylin analog studied in laboratory research for its interactions with amylin receptors and metabolic regulatory pathways governing satiety and energy homeostasis
Buy 1
SAVE 0%
Buy 3
SAVE 20%
Buy 5
SAVE 33%
Buy 7+
SAVE 50%
Description
Cagrilintide is a long-acting synthetic amylin analog designed to activate amylin receptors (AMY1, AMY2, AMY3) in the hypothalamus and brainstem — receptor complexes associated with satiety signaling, gastric emptying regulation, and energy balance. Originally developed by Novo Nordisk and currently under active clinical investigation, cagrilintide has been the subject of research examining amylin receptor biology and its role in appetite and metabolic regulation.
Growing scientific interest in cagrilintide has been driven in part by its investigation in combination with semaglutide (as the compound “CagriSema”), which has shown additive metabolic effects in clinical research. Laboratory research into cagrilintide supports investigation of amylin receptor pharmacology and the neurobiology of satiety signaling.
Supplied as a lyophilized Research Use Only (RUO) material, analytically verified for identity and purity with batch-specific Certificate of Analysis documentation.
